Physician profile
Peter Marogil
NPI 1528447331
$25,262.36
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.38 · 2020: $90.60 · 2021: $115 · 2022: $23K · 2023: $1,880 · 2024: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,147 · Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,147.48 |
| Food and Beverage | $1,110.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,476.20 | 2022-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Thoratec Heartmate II, Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.76 | 2021-2022 | |
| Paragonix Technologies, INC. | $160.04 | 2024 | |
| Cardiovascular Systems INC. | $144.48 | 2022 | |
| Cvrx, INC. | $112.66 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.26 | 2020-2022 | |
| Amgen INC. | $54.29 | 2020-2021 | |
| Boston Scientific Corporation | $40.85 | 2020-2022 | |
| Lantheus Medical Imaging, INC. | $18.44 | 2020 | |
| Ekos Corporation | $16.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Marogil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.